AML Regression by Vascular Disruption with OXi4503 and Anti-Angiogenesis with Bevacizumab.
Gerard J. Madlambayan(University of Rochester), Christopher R. Cogle(University of Florida), Marda Jorgensen(University of Florida), Amy Meacham(University of Florida), Edward W. Scott(University of Florida), Dietmar W. Siemann(University of Florida Health), Saad Mir, Koji Hosaka(Institute for Stem Cell Biology and Regenerative Medicine)
Cited by 0
Related Papers
Alginate hydrogels as synthetic extracellular matrix materials
|Biomaterials|1999|2.3k
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
|Cell Metabolism|2020|179
Cell–cell interaction networks regulate blood stem and progenitor cell fate
|Molecular Systems Biology|2009|125